Comparison of One Anastomosis Gastric Bypass Versus Standard Roux-en-Y Gastric Bypass Versus a Variant of Biliopancreatic Diversion, in a Case-matched, Non-superobese Population: 6 Years of Follow-up

Overview

Journal Prz Gastroenterol

Publisher Termedia

Specialty Gastroenterology

Date 2022 Jun 6

PMID 35664023

Authors

George Markopoulos

George Skroubis

Fotis Kalfarentzos

Ioannis Kehagias

Affiliations

Soon will be listed here.

Abstract

Introduction: One anastomosis gastric bypass (OAGB) is gaining increasing acceptance as a simple, safe, and effective operation for treating morbid obesity. Data comparing this procedure with the most effective biliopancreatic diversions (BPD) remain scarce, and most studies evaluate OAGB against standard Roux-en-Y gastric bypass (RYGB).

Aim: To present the mid-term results of a comparison of RYGB, OAGB, and our modification of BPD in an exclusively non-superobese population, regarding safety, efficacy, preservation of weight loss, as well as late postoperative metabolic and non-metabolic complications.

Material And Methods: From our cohorts of patients treated for morbid obesity with OAGB, RYGB, and BPD at Patras University Hospital, we identified patients who had case-matched preoperative profiles regarding age, preoperative body mass index (BMI), and obesity-related comorbidities (diabetes mellitus, hypertension, and dyslipidaemia). Thirty-four patients from each group were included in the study. Bariatric outcomes, non-metabolic complications, and postoperative metabolic parameters were followed until the 6 postoperative year.

Results: The average patient age was 37.4 years (range: 19-57), 85.3% were female and 14.7% were male, with a mean BMI of 46.3 kg/m (range: 38.3-49.7). Regarding weight loss and glycaemic control, OAGB had comparable results to BPD and was significantly better than RYGB. The safety profile was analogous to RYGB, with the exception of calcium levels, which, even though they were within normal range, were significantly lower than those in RYGB. Comorbidities were successfully treated with all operations at comparable rates. In this cohort, no other major complications were observed.

Conclusions: OAGB offered mid-term results comparable to BPD while being safe and with minimal impact on the patient's nutritional state. It is an effective procedure for treating morbid obesity, which results in sustained weight loss and a high rate of resolution of comorbidities.

Citing Articles

Comparison between low molecular weight heparin and apixaban (direct oral anticoagulant) in the prophylaxis against venous thromboembolism after laparoscopic sleeve gastrectomy.

Abdelsalam A, Fikry M, Fahmy A, Hegazy T, Hamdy A, Refaat A Obes Surg. 2025; 35(3):934-940.

PMID: 39921824 PMC: 11906520. DOI: 10.1007/s11695-025-07721-y.

One Anastomosis Gastric Bypass as Revisional Surgery Following Sleeve Gastrectomy: A Systematic Review and Meta-Analysis.

Nakanishi H, Abi Mosleh K, Al-Kordi M, Farsi S, Chaudhry S, Marrero K Obes Surg. 2024; 34(2):429-441.

PMID: 38198098 DOI: 10.1007/s11695-024-07056-0.

Marginal Ulcers Following One-Anastomosis Gastric Bypass: a Systematic Review and Meta-analysis.

Lee S, Supparamaniam S, Varghese C, Mahawar K Obes Surg. 2023; 33(9):2884-2897.

PMID: 37526816 DOI: 10.1007/s11695-023-06762-5.

The impact of bariatric surgery procedures on the modulation of cardiometabolic risk factors in patients with severe obesity: a 12-month follow-up.

Tabesh M, Abolhasani M, Zali M, Bagheri R, Alipour M, Cheraghloo N J Int Med Res. 2022; 50(10):3000605221119657.

PMID: 36314880 PMC: 9629577. DOI: 10.1177/03000605221119657.

References

Pournaras D, Aasheim E, Bueter M, Ahmed A, Welbourn R, Olbers T . Effect of bypassing the proximal gut on gut hormones involved with glycemic control and weight loss. Surg Obes Relat Dis. 2012; 8(4):371-4. DOI: 10.1016/j.soard.2012.01.021. View

Kalfarentzos F, Skroubis G, Karamanakos S, Argentou M, Mead N, Kehagias I . Biliopancreatic diversion with Roux-en-Y gastric bypass and long limbs: advances in surgical treatment for super-obesity. Obes Surg. 2011; 21(12):1849-58. DOI: 10.1007/s11695-011-0532-9. View

Switzer N, Marcil G, Prasad S, Debru E, Church N, Mitchell P . Long-term hypovitaminosis D and secondary hyperparathyroidism outcomes of the Roux-en-Y gastric bypass: a systematic review. Obes Rev. 2017; 18(5):560-566. DOI: 10.1111/obr.12525. View

Musella M, Susa A, Greco F, De Luca M, Manno E, Di Stefano C . The laparoscopic mini-gastric bypass: the Italian experience: outcomes from 974 consecutive cases in a multicenter review. Surg Endosc. 2013; 28(1):156-63. DOI: 10.1007/s00464-013-3141-y. View

White M, Ward M, Applewhite M, Wong H, Prachand V, Angelos P . Rates of secondary hyperparathyroidism after bypass operation for super-morbid obesity: An overlooked phenomenon. Surgery. 2016; 161(3):720-726. DOI: 10.1016/j.surg.2016.08.046. View

Saarinen T, Rasanen J, Salo J, Loimaala A, Pitkonen M, Leivonen M . Bile Reflux Scintigraphy After Mini-Gastric Bypass. Obes Surg. 2017; 27(8):2083-2089. DOI: 10.1007/s11695-017-2608-7. View

De Luca M, Tie T, Ooi G, Higa K, Himpens J, Carbajo M . Mini Gastric Bypass-One Anastomosis Gastric Bypass (MGB-OAGB)-IFSO Position Statement. Obes Surg. 2018; 28(5):1188-1206. DOI: 10.1007/s11695-018-3182-3. View

Mahawar K . A Biliopancreatic Limb of >150 cm with OAGB/MGB Is Ill-Advised. Obes Surg. 2017; 27(8):2164-2165. DOI: 10.1007/s11695-017-2736-0. View

Taha O, Abdelaal M, Abozeid M, Askalany A, Alaa M . Outcomes of Omega Loop Gastric Bypass, 6-Years Experience of 1520 Cases. Obes Surg. 2017; 27(8):1952-1960. DOI: 10.1007/s11695-017-2623-8. View

10.

Bevilacqua L, Obeid N, Yang J, Zhu C, Altieri M, Spaniolas K . Incidence of GERD, esophagitis, Barrett's esophagus, and esophageal adenocarcinoma after bariatric surgery. Surg Obes Relat Dis. 2020; 16(11):1828-1836. DOI: 10.1016/j.soard.2020.06.016. View

11.

Buchwald H . A bariatric surgery algorithm. Obes Surg. 2003; 12(6):733-46; discussion 747-50. DOI: 10.1381/096089202320995484. View

12.

Lee W, Ser K, Lee Y, Tsou J, Chen S, Chen J . Laparoscopic Roux-en-Y vs. mini-gastric bypass for the treatment of morbid obesity: a 10-year experience. Obes Surg. 2012; 22(12):1827-34. DOI: 10.1007/s11695-012-0726-9. View

13.

Musella M, Susa A, Manno E, De Luca M, Greco F, Raffaelli M . Complications Following the Mini/One Anastomosis Gastric Bypass (MGB/OAGB): a Multi-institutional Survey on 2678 Patients with a Mid-term (5 Years) Follow-up. Obes Surg. 2017; 27(11):2956-2967. DOI: 10.1007/s11695-017-2726-2. View

14.

Tolone S, Cristiano S, Savarino E, Lucido F, Fico D, Docimo L . Effects of omega-loop bypass on esophagogastric junction function. Surg Obes Relat Dis. 2015; 12(1):62-9. DOI: 10.1016/j.soard.2015.03.011. View

15.

Lupoli R, Lembo E, Saldalamacchia G, Avola C, Angrisani L, Capaldo B . Bariatric surgery and long-term nutritional issues. World J Diabetes. 2017; 8(11):464-474. PMC: 5700383. DOI: 10.4239/wjd.v8.i11.464. View

16.

Skroubis G, Kouri N, Mead N, Kalfarentzos F . Long-term results of a prospective comparison of Roux-en-Y gastric bypass versus a variant of biliopancreatic diversion in a non-superobese population (BMI 35-50 kg/m(2)). Obes Surg. 2013; 24(2):197-204. DOI: 10.1007/s11695-013-1081-1. View

17.

Mahawar K, Borg C, Kular K, Courtney M, Sillah K, Carr W . Understanding Objections to One Anastomosis (Mini) Gastric Bypass: A Survey of 417 Surgeons Not Performing this Procedure. Obes Surg. 2017; 27(9):2222-2228. DOI: 10.1007/s11695-017-2663-0. View

18.

Buchwald H . Overview of bariatric surgery. J Am Coll Surg. 2002; 194(3):367-75. DOI: 10.1016/s1072-7515(01)01175-9. View

19.

Parmar C, Mahawar K, Boyle M, Carr W, Jennings N, Schroeder N . Mini Gastric Bypass: first report of 125 consecutive cases from United Kingdom. Clin Obes. 2016; 6(1):61-7. DOI: 10.1111/cob.12124. View

20.

Lee W, Lin Y . Single-anastomosis gastric bypass (SAGB): appraisal of clinical evidence. Obes Surg. 2014; 24(10):1749-56. DOI: 10.1007/s11695-014-1369-9. View